Gillmore, R., Stuart, S., Kirkwood, A., Hameeduddin, A., Woodward, N., Burroughs, A. K., & Meyer, T. (2011). EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. Journal of Hepatology, 55(6), 1309. https://doi.org/10.1016/j.jhep.2011.03.007
Chicago Style (17th ed.) CitationGillmore, Roopinder, Sam Stuart, Amy Kirkwood, Ayshea Hameeduddin, Nick Woodward, Andrew K. Burroughs, and Tim Meyer. "EASL and MRECIST Responses Are Independent Prognostic Factors for Survival in Hepatocellular Cancer Patients Treated with Transarterial Embolization." Journal of Hepatology 55, no. 6 (2011): 1309. https://doi.org/10.1016/j.jhep.2011.03.007.
MLA (9th ed.) CitationGillmore, Roopinder, et al. "EASL and MRECIST Responses Are Independent Prognostic Factors for Survival in Hepatocellular Cancer Patients Treated with Transarterial Embolization." Journal of Hepatology, vol. 55, no. 6, 2011, p. 1309, https://doi.org/10.1016/j.jhep.2011.03.007.